Get started
Author

Bård Mannsåker

Observed names: B. Mannsåker, BARD MANNSAKER, BARD MANNSÅKER, Bard Mannsaker, BÅRD MANNSÅKER, BÅRD MÅNNSAKER, BĂRD MANNSĂKER
Observed institutions: Oslo University Hospital, Norwegian University of Science and Technology, Haukeland University Hospital, Nordland Hospital Trust, Nordland Hospital, Växjö Kommun, University of Bergen, UiT The Arctic University of Norway, University of Stavanger
ORCID: 0009-0007-6730-5473
Observed ORCID: 0009-0007-6730-5473
OpenAlex ID: A5016685170
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
2017 · Johanna Huun, Liv B. Gansmo, et al. · BMC Cell Biology · 23
PDF
Polypharmacy in Older Patients ≥70 Years Receiving Palliative Radiotherapy
2017 · CARSTEN NIEDER, BĂRD MANNSĂKER, et al. · Anticancer Research · 21
PDF
Palliative radiotherapy with or without additional care by a multidisciplinary palliative care team in patients with newly diagnosed cancer: a retrospective matched pairs comparison
2015 · Carsten Nieder, Astrid Dalhaug, et al. · Radiation Oncology · 18
PDF
Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?
2021 · CARSTEN NIEDER, ELLINOR C. HAUKLAND, et al. · In Vivo · 17
PDF
Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
2019 · Carsten Nieder, Ellinor Haukland, et al. · Cureus · 17
PDF
Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases
2016 · CARSTEN NIEDER, ASTRID DALHAUG, et al. · In Vivo · 17
PDF
Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients
2013 · Kristoffer Evebø Sand, Kristin Paulsen Rye, et al. · OncoImmunology · 17
PDF
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
2024 · H.O. Ohnstad, E.S. Blix, et al. · ESMO Open · 16
PDF
Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases
2021 · CARSTEN NIEDER, BÅRD MANNSÅKER, et al. · Anticancer Research · 16
PDF
Prognostic Impact of the Tumor Marker CA 15-3 in Patients With Breast Cancer and Bone Metastases Treated With Palliative Radiotherapy
2017 · Carsten Nieder, Astrid Dalhaug, et al. · Journal of Clinical Medicine Research · 16
PDF
Palliative Radiotherapy in Cancer Patients with Increased Serum C-Reactive Protein Level.
2016 · Carsten Nieder, Bård Mannsåker, et al. · PubMed · 15
30-day mortality in patients treated for brain metastases: extracranial causes dominate
2022 · Carsten Nieder, Luka Stanisavljevic, et al. · Radiation Oncology · 14
PDF
Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery
2018 · Carsten Nieder, Rosalba Yobuta, et al. · Cureus · 14
PDF
Risk factors for esophagitis after hypofractionated palliative (chemo) radiotherapy for non-small cell lung cancer
2020 · Carsten Nieder, Kristian S. Imingen, et al. · Radiation Oncology · 13
PDF
Early palliative radiation therapy in patients with newly diagnosed cancer: Reasons, clinical practice, and survival
2015 · Carsten Nieder, Ellinor Haukland, et al. · Practical Radiation Oncology · 12
Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer
2016 · Carsten Nieder, Ellinor Haukland, et al. · Oncology Letters · 11
PDF
Tumor marker analyses in patients with brain metastases: patterns of practice and implications for survival prediction research
2015 · Carsten Nieder, Astrid Dalhaug, et al. · Tumor Biology · 10
Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance
2017 · Carsten Nieder, Astrid Dalhaug, et al. · International Journal of Circumpolar Health · 9
PDF
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
2017 · Øystein Fluge, Bård Mannsåker, et al. · Clinical Lymphoma Myeloma & Leukemia · 8
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study
2023 · Jürgen Geisler, Peeter Karihtala, et al. · Acta Oncologica · 7
PDF
The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells
2017 · Johanna Huun, Liv B. Gansmo, et al. · Translational Oncology · 7
PDF
Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors
2023 · Carsten Nieder, Luka Stanisavljevic, et al. · Radiation Oncology · 6
PDF
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
2023 · Carsten Nieder, Ellinor C. Haukland, et al. · Strahlentherapie und Onkologie · 6
PDF
Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
2022 · CARSTEN NIEDER, ASTRID DALHAUG, et al. · In Vivo · 6
PDF
Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
2021 · CARSTEN NIEDER, KRISTIAN S. IMINGEN, et al. · Anticancer Research · 6
PDF
Works count: 69
Citation count: 410
H-index: 13
I10-index: 17
Year
Topic
Type